Gene Transfer in Skeletal and Cardiac Muscle Using Recombinant Adeno‐Associated Virus

Adeno‐associated virus (AAV) is a DNA virus with a small (∼4.7 kb) single‐stranded genome. It is a naturally replication‐defective parvovirus of the dependovirus group. Recombinant AAV (rAAV), for use as a gene transfer vector, is created by replacing the viral rep and cap genes with the transgene of interest along with promoter and polyadenylation sequences. Only the viral inverted terminal repeats (ITRs) are required in cis for replication and packaging during production. The ITRs are also necessary and sufficient for vector genome processing and persistence during transduction. The tissue tropism of the rAAV vector is determined by the AAV capsid. In this unit we will discuss several methods to deliver rAAV in order to transduce cardiac and/or skeletal muscle, including intravenous delivery, intramuscular delivery, isolated limb infusion, intrapericardial injection in neonatal mice, and left ventricular wall injection in adult rats. Curr. Protoc. Microbiol. 28:14D.3.1‐14D.3.19. © 2013 by John Wiley & Sons, Inc.

[1]  D. Duan,et al.  Novel mini-dystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma. , 2012, Human gene therapy.

[2]  J. Shin,et al.  Improvement of cardiac fibrosis in dystrophic mice by rAAV9-mediated microdystrophin transduction , 2011, Gene Therapy.

[3]  N. Miyake,et al.  Direct Comparison of Four Adeno-Associated Virus Serotypes in Mediating the Production of Antiangiogenic Proteins in Mouse Muscle , 2011, Cancer investigation.

[4]  H. Sweeney,et al.  Transendocardial delivery of AAV6 results in highly efficient and global cardiac gene transfer in rhesus macaques. , 2011, Human gene therapy.

[5]  Stefan L Ameres,et al.  MicroRNA-regulated, Systemically Delivered rAAV9: A Step Closer to CNS-restricted Transgene Expression , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  S. Acton,et al.  Robust Cardiomyocyte-Specific Gene Expression Following Systemic Injection of AAV: In Vivo Gene Delivery Follows a Poisson Distribution , 2010, Gene Therapy.

[7]  Juan Li,et al.  Gene therapy in skeletal muscle mediated by adeno-associated virus vectors. , 2011, Methods in molecular biology.

[8]  R. Samulski,et al.  Systemic gene transfer to skeletal muscle using reengineered AAV vectors. , 2011, Methods in molecular biology.

[9]  H. Sweeney,et al.  Adeno-associated virus vector delivery to the heart. , 2011, Methods in molecular biology.

[10]  Songtao Li,et al.  Hydrostatic Isolated Limb Perfusion with Adeno-associated Virus Vectors Enhances Correction of Skeletal Muscle in Pompe Disease , 2010, Gene Therapy.

[11]  C. Zhang,et al.  Efficient retrograde transport of adeno-associated virus type 8 to spinal cord and dorsal root ganglion after vector delivery in muscle. , 2010, Human gene therapy.

[12]  H. Sweeney,et al.  Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. , 2008, Human gene therapy.

[13]  Freddie H. Fu,et al.  Construction and analysis of compact muscle-specific promoters for AAV vectors , 2008, Gene Therapy.

[14]  J. Rabinowitz,et al.  Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  J. Mendell,et al.  A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy , 2007, Journal of Translational Medicine.

[16]  A. Remppis,et al.  Stable Myocardial-Specific AAV6-S100A1 Gene Therapy Results in Chronic Functional Heart Failure Rescue , 2007, Circulation.

[17]  Woo Jin Park,et al.  Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. , 2007, Journal of molecular and cellular cardiology.

[18]  Theresa A. Storm,et al.  Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  Theresa A. Storm,et al.  Liver Transduction with Recombinant Adeno-Associated Virus Is Primarily Restricted by Capsid Serotype Not Vector Genotype , 2006, Journal of Virology.

[20]  D. Lewis,et al.  A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  M. R. Delgado Alvira,et al.  Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues , 2004, Journal of Virology.

[22]  H. Sweeney,et al.  Efficient transmural cardiac gene transfer by intrapericardial injection in neonatal mice. , 1998, Journal of molecular and cellular cardiology.

[23]  O. Carretero,et al.  Chronic heart failure induced by coronary artery ligation in Lewis inbred rats. , 1997, The American journal of physiology.

[24]  T. Flotte,et al.  In vivo model of adeno-associated virus vector persistence and rescue , 1996, Journal of virology.

[25]  T. Flotte,et al.  Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. , 1994, American journal of respiratory cell and molecular biology.